
Michael Drazer
@michaelwd_hem
Physician-scientist @ the intersection of genetics, hematology/oncology, & patient care. Runner. Tweets are my own - no COI. Scholar: shorturl.at/r7pPC
ID: 1890360697558822913
http://thedrazergroup.org 14-02-2025 11:21:41
4 Tweet
8 Followers
129 Following

We're very excited to announce our class of incoming Hem/Onc fellows, the class of 2028! University of Chicago Hematology/Oncology








Check out this study led by Anand Patel Toyosi Odenike Michael Drazer investigating the LSD1 inhibitor iadademstat combined with ASTX727 in accelerated/blast-phase MPNs! clinicaltrials.gov/study/NCT06661…



In a case-based panel, Ben Derman, MD, joined other panelists, Neha Korde,MD, Luciano Costa, MD, PhD, and Rebecca Silberman, MD, to discuss the best strategies to incorporate MRD into the treatment of MM patients. Luciano J Costa Ben Derman University of Chicago Hematology/Oncology


Congratulations to our fellows Alexandra Rojek, Joseph Cannova, Dan Peiffer, and their wonderful mentors on their ASCO YIAs. Thank you Conquer Cancer, the ASCO Foundation ASCO for supporting the career development of our fellows. University of Chicago Hematology/Oncology #ASCO25



Our faculty in the media 📰🖥️ !! Coverage of Dr. Duvall's Hope Award from the Lymphoma Research Foundation Research Foundation fox32chicago.com/news/chicago-t… and a great new piece in JCO Oncology Practice by University of Chicago Hem/Onc Fellows Dr. Wu ascopubs.org/doi/10.1200/OP…!!! Adam DuVall MD, MPH UChicago Medicine



🚨 New research finds women with BRCA1/2 mutations who received textured breast implants after mastectomy face a 16x higher risk of developing BIA-ALCL, a rare lymphoma. Study highlights need for awareness years after surgery. 🔗 ow.ly/ALWv50W94IZ Blood Journals Portfolio


new research led by Rafael Madero Marroquín Anand Patel and featuring several UChicago Leukemia Program program members that reports using of additional venetoclax-containing regimens in pts prev treated w HMA+VEN dx.doi.org/10.1002/jha2.7…


